Airway Epithelium Respiratory Illnesses and Allergy (AERIAL) birth cohort: study protocol
Authors:
- Elizabeth Kicic-StarcevichEKElizabeth Kicic-Starcevich
- David G HancockDHDavid G Hancock
- Thomas IosifidisTIThomas Iosifidis
- Patricia Agudelo-RomeroPAPatricia Agudelo-Romero
- Jose A Caparros-MartinJose A Caparros-Martin
- Desiree SilvaDSDesiree Silva
- Lidija TurkovicLTLidija Turkovic
- Peter N Le SouefPSPeter N Le Souef
- Anthony BoscoABAnthony Bosco
- David J MartinoDMDavid J Martino
- Anthony KicicAKAnthony Kicic
- Susan L PrescottSPSusan L Prescott
Preprint
Abstract
Introduction: Recurrent wheezing disorders including asthma are complex and heterogeneous diseases that affect up to 30% of all children, contributing to a major burden on children, their families, and global healthcare systems. It is now recognized that a dysfunctional airway epithelium plays a central role in the pathogenesis of recurrent wheeze, although the underlying mechanisms are still not fully understood. This prospective birth cohort aims to bridge this knowledge gap by investigating the influence of intrinsic epithelial dysfunction on the risk for developing respiratory disorders and the modulation of this risk by maternal morbidities, in utero exposures, and respiratory exposures in the first year of life. Methods and Analysis: The Airway Epithelium Respiratory Illnesses and Allergy (AERIAL) study is nested within the ORIGINS Project and will monitor 400 infants from birth to five years. The primary outcome of the AERIAL study will be the identification of epithelial endotypes and exposure variables that influence the development of recurrent wheezing, asthma, and allergic sensitisation. Nasal respiratory epithelium at birth to six weeks, one, three, and five years will be analysed by bulk RNA-seq and DNA methylation sequencing. Maternal morbidities and in utero exposures will be identified on maternal history and their effects measured through transcriptomic and epigenetic analyses of the amnion and newborn epithelium. Exposures within the first year of life will be identified based on infant medical history as well as on background and symptomatic nasal sampling for viral PCR and microbiome analysis. Daily temperatures and symptoms recorded in a study-specific Smartphone App will be used to identify symptomatic respiratory illnesses. Ethics and Dissemination: Ethical approval has been obtained from Ramsey Health Care HREC WA-SA (#1908). Results will be disseminated through open-access peer-reviewed manuscripts, conference presentations, and through different media channels to consumers, ORIGINS families, and the wider community.Keywords
All Related Versions
- Published version: Frontiers in Allergy, 5, 1349741.
This publication has 42 references indexed in Scilit:
- Culture of Airway Epithelial Cells from Neonates Sampled within 48-Hours of BirthPLOS ONE, 2013
- DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic ChildrenPLOS ONE, 2012
- Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 yearsThorax, 2012
- Genetic and genomic approaches to asthmaCurrent Opinion in Pulmonary Medicine, 2012
- The sentinel role of the airway epithelium in asthma pathogenesisImmunological Reviews, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- A Large-Scale, Consortium-Based Genomewide Association Study of AsthmaNew England Journal of Medicine, 2010
- International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resourcesThorax, 2010
- Decreased Fibronectin Production Significantly Contributes to Dysregulated Repair of Asthmatic EpitheliumAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor‐1Clinical & Experimental Allergy, 2008